Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group

Additional Metadata
Keywords	Infant acute lymphoblastic leukemia, Mortality
Persistent URL	doi.org/10.1002/pbc.25311, hdl.handle.net/1765/87321
Journal	Pediatric Blood & Cancer
Organisation	Department of Pediatrics
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Salzer, W. L., Jones, T. L., Devidas, M., Dreyer, S. D., Gore, L., Winick, N., Sung, L., Raetz, E., Loh, M., Wang, C. Y., de Lorenzo, P., Valsecchi, M. G., Pieters, R., Carroll, W. L., Hunger, S., Hilden, J.& Brown, P. (2015). Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group. Pediatric Blood & Cancer, 62(3), 414–418.https://doi.org/10.1002/pbc.25311

Publication